{"pmid":32273254,"title":"Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic.","text":["Cannabidiol as prophylaxis for SARS-CoV-2 and COVID-19? Unfounded claims versus potential risks of medications during the pandemic.","Res Social Adm Pharm","Brown, Joshua D","32273254"],"journal":"Res Social Adm Pharm","authors":["Brown, Joshua D"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32273254","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.sapharm.2020.03.020","source":"PubMed","locations":["Cannabidiol"],"topics":["Treatment"],"weight":1,"e_drugs":["Cannabidiol"],"_version_":1663712077850607616,"score":7.9164424,"similar":[{"pmid":32231348,"title":"Emerging prophylaxis strategies against COVID-19.","text":["Emerging prophylaxis strategies against COVID-19.","The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus.","Monaldi Arch Chest Dis","Agrawal, Sumita","Goel, Akhil Dhanesh","Gupta, Nitesh","32231348"],"abstract":["The Novel corona virus 2019 which started as an outbreak in China in December 2019 has rapidly spread all over the world, such that on 11th March 2020 WHO declared this disease as pandemic. The emergency that the world faces today demands that we develop urgent and effective measures to protect people at high risk of transmission. WHO has accelerated research in diagnostics, vaccines and therapeutics for this novel coronavirus."],"journal":"Monaldi Arch Chest Dis","authors":["Agrawal, Sumita","Goel, Akhil Dhanesh","Gupta, Nitesh"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32231348","week":"202014|Mar 30 - Apr 05","doi":"10.4081/monaldi.2020.1289","source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663352135343931392,"score":59.753876},{"pmid":32201354,"pmcid":"PMC7102597","title":"SARS-CoV-2: fear versus data.","text":["SARS-CoV-2: fear versus data.","SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-COV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing.","Int J Antimicrob Agents","Roussel, Yanis","Giraud-Gatineau, Audrey","Jimeno, Marie-Therese","Rolain, Jean-Marc","Zandotti, Christine","Colson, Philippe","Raoult, Didier","32201354"],"abstract":["SARS-CoV-2, the novel coronavirus from China, is spreading around the world, causing a huge reaction despite its current low incidence outside China and the Far East. Four common coronaviruses are in current circulation and cause millions of cases worldwide. This article compares the incidence and mortality rates of these four common coronaviruses with those of SARS-COV-2 in Organisation for Economic Co-operation and Development countries. It is concluded that the problem of SARS-CoV-2 is probably being overestimated, as 2.6 million people die of respiratory infections each year compared with less than 4000 deaths for SARS-CoV-2 at the time of writing."],"journal":"Int J Antimicrob Agents","authors":["Roussel, Yanis","Giraud-Gatineau, Audrey","Jimeno, Marie-Therese","Rolain, Jean-Marc","Zandotti, Christine","Colson, Philippe","Raoult, Didier"],"date":"2020-03-24T11:00:00Z","year":2020,"_id":"32201354","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.ijantimicag.2020.105947","keywords":["COVID-19","Coronavirus","SARS-CoV-2"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"weight":0,"_version_":1663352133644189696,"score":55.125847},{"pmid":32278018,"title":"Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.","text":["Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society.","Not needed.","Indian Pacing Electrophysiol J","Kapoor, Aditya","Pandurangi, Ulhas","Arora, Vanita","Gupta, Anoop","Jaswal, Aparna","Nabar, Ashish","Naik, Ajay","Naik, Nitish","Namboodiri, Narayanan","Vora, Amit","Yadav, Rakesh","Saxena, Anil","32278018"],"abstract":["Not needed."],"journal":"Indian Pacing Electrophysiol J","authors":["Kapoor, Aditya","Pandurangi, Ulhas","Arora, Vanita","Gupta, Anoop","Jaswal, Aparna","Nabar, Ashish","Naik, Ajay","Naik, Nitish","Namboodiri, Narayanan","Vora, Amit","Yadav, Rakesh","Saxena, Anil"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32278018","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.ipej.2020.04.003","keywords":["COVID-19","Heart disease","Hydroxychloroquine","QTc interval","Torsade de pointes"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1663798882994225152,"score":52.326473},{"pmid":32102621,"pmcid":"PMC7054935","title":"No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2.","text":["No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2.","Emerg Microbes Infect","Liu, Shan-Lu","Saif, Linda J","Weiss, Susan R","Su, Lishan","32102621"],"journal":"Emerg Microbes Infect","authors":["Liu, Shan-Lu","Saif, Linda J","Weiss, Susan R","Su, Lishan"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32102621","week":"20209|Feb 24 - Mar 01","doi":"10.1080/22221751.2020.1733440","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1663352134455787520,"score":45.31516},{"pmid":32148173,"title":"Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination.","text":["Is SARS-CoV-2 originated from laboratory? A rebuttal to the claim of formation via laboratory recombination.","Emerg Microbes Infect","Hao, Pei","Zhong, Wu","Song, Shiyang","Fan, Shiyong","Li, Xuan","32148173"],"journal":"Emerg Microbes Infect","authors":["Hao, Pei","Zhong, Wu","Song, Shiyang","Fan, Shiyong","Li, Xuan"],"date":"2020-03-10T11:00:00Z","year":2020,"_id":"32148173","week":"202011|Mar 09 - Mar 15","doi":"10.1080/22221751.2020.1738279","source":"PubMed","topics":["Mechanism"],"weight":1,"_version_":1663352134141214721,"score":43.19069}]}